Current perspectives in the treatment of metastatic colorectal cancer-Reference-Cited by-同舟云学术

Current perspectives in the treatment of metastatic colorectal cancer

Published:2004-10 Issue: Volume:15 Page:iv43-iv53
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Köhne C.-H.,Folprecht G.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/15/suppl_4/iv43/450649/mdh904.pdf

Reference95 articles.

1. Advanced Colorectal Cancer Meta-Analysis Project;J Clin Oncol,1992

2. Survival benefit of 5FU/LV over 5FU bolus in patients with advanced colorectal cancer: An updated meta-analysis based on 2,751 patients;Piedbois;Proc Am Soc Clin Oncol,2003

3. Toxicity of irinotecan in patients with colorectal cancer;Van Cutsem;N Engl J Med,2001

4. Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multicentre randomised trial;Maughan;Lancet,2003

5. Patient preferences for oral versus intravenous palliative chemotherapy;Liu;J Clin Oncol,1997

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic factors for the presence of the methastasis in lymph nodes and organs in Bulgarien patients with colorectal carcinoma;AIP Conference Proceedings;2018

2. Factors that influence survival in colorectal cancer with synchronous distant metastasis;Journal of the Chinese Medical Association;2012-08

3. Prognostic impact of intrahepatic lymphatic and microvascular involvement in cases of colorectal liver metastases;International Journal of Colorectal Disease;2009-02-25

4. Antikörpertherapie in der Hämatologie und Onkologie – Teil 2*;Medizinische Klinik;2009-01

5. Dihydropyrimidine dehydrogenases and cytidine-deaminase gene polymorphisms as outcome predictors in resected gastric cancer patients treated with fluoropyrimidine adjuvant chemotherapy;Journal of Surgical Oncology;2008-06-06